Pathology & Oncology Research

, Volume 2, Issue 4, pp 242–243

M-ESLON® (retard release morphine sulphate capsules) for pain control in cancer patients

  • Attila J Horváth
  • Anita Szabó
  • Tünde Gáspár
  • Lajos Bognár
  • Miklñs Tekeres
Short Communication
Received:
Accepted:

DOI: 10.1007/BF02904818

Cite this article as:
Horváth, A.J., Szabó, A., Gáspár, T. et al. Pathol. Oncol. Res. (1996) 2: 242. doi:10.1007/BF02904818

Abstract

The pain of patients who were in the terminal phase of advanced malignant tumors was successfully relieved by M-ESLON® capsules of controlled release morphine sulphate (10-30-60-100 mg). The most frequent side effects (sickness, vomiting, obstipation) were effectively controlled. The concentration of the drug in the plasma was stable, therefore the lasting pain relief was ensured.

Key words

eaneer pain morphine sulphate controlled release side effects 

Copyright information

© Arányi Lajos Foundation 1996

Authors and Affiliations

  • Attila J Horváth
    • 1
  • Anita Szabó
    • 1
  • Tünde Gáspár
    • 1
  • Lajos Bognár
    • 1
  • Miklñs Tekeres
    • 1
  1. 1.Institute of Anaesthesiolcgy and Intensive TherapyUniversity of MedieinePéesHungary
  2. 2.Institute of Anaesthesiology and Intensive TherapyUniversity of MedicinePécsHungary

Personalised recommendations